Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Aug;26(8):1774-82.
doi: 10.1002/jbmr.372.

WHO absolute fracture risk models (FRAX): do clinical risk factors improve fracture prediction in older women without osteoporosis?

Affiliations

WHO absolute fracture risk models (FRAX): do clinical risk factors improve fracture prediction in older women without osteoporosis?

Teresa A Hillier et al. J Bone Miner Res. 2011 Aug.

Abstract

Bone mineral density (BMD) is a strong predictor of fracture, yet most fractures occur in women without osteoporosis by BMD criteria. To improve fracture risk prediction, the World Health Organization recently developed a country-specific fracture risk index of clinical risk factors (FRAX) that estimates 10-year probabilities of hip and major osteoporotic fracture. Within differing baseline BMD categories, we evaluated 6252 women aged 65 or older in the Study of Osteoporotic Fractures using FRAX 10-year probabilities of hip and major osteoporotic fracture (ie, hip, clinical spine, wrist, and humerus) compared with incidence of fractures over 10 years of follow-up. Overall ability of FRAX to predict fracture risk based on initial BMD T-score categories (normal, low bone mass, and osteoporosis) was evaluated with receiver-operating-characteristic (ROC) analyses using area under the curve (AUC). Over 10 years of follow-up, 368 women incurred a hip fracture, and 1011 a major osteoporotic fracture. Women with low bone mass represented the majority (n = 3791, 61%); they developed many hip (n = 176, 48%) and major osteoporotic fractures (n = 569, 56%). Among women with normal and low bone mass, FRAX (including BMD) was an overall better predictor of hip fracture risk (AUC = 0.78 and 0.70, respectively) than major osteoporotic fractures (AUC = 0.64 and 0.62). Simpler models (eg, age + prior fracture) had similar AUCs to FRAX, including among women for whom primary prevention is sought (no prior fracture or osteoporosis by BMD). The FRAX and simpler models predict 10-year risk of incident hip and major osteoporotic fractures in older US women with normal or low bone mass.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: JAC is a consultant for Novartis, and has received research funding from Novartis. DCB has received research funding from Novartis, Merck and Amgen. DMB is a consultant for Amgen and has received research funding from Novartis, Roche, Merck, and Amgen.

Figures

Figure 1
Figure 1
FRAX predicted 10-year hip probabilities with FN BMD are compared to observed fracture across baseline BMD increments. Observed fractures are plotted as total number of fractures for each BMD T-score group, and BMD distribution of the population is indicated on each graph. FRAX hip probabilities were used to predict hip fracture; major osteoporotic probabilities were used to predict major osteoporotic fractures. Major osteoporotic fractures were defined as hip, clinical spine, wrist and humerus.(6) *p<0.05 by paired t-tests of predicted vs. observed fractures in each respective 0.5 BMD T-score increment.
Figure 2
Figure 2
Proportion of women with low bone mass (n=4464) at baseline exam that would meet current National Osteoporosis (NOF) treatment thresholds (high-risk; n=2218) or not (low-risk; n=2246), with further stratification on whether fracture occurred in 10 years of follow-up. NOF high-risk is low bone mass (T score between −1.0 and −2.5 by femoral neck or spine BMD) and 10 year FRAX (including BMD) probability of fracture of ≥3% for hip and ≥20% for major osteoporotic fracture (MOF).(7) Proportions are illustrated for the whole cohort (n=4,464), as well as by a prior history of fracture (n=1505) or no prior fracture history (n=2,959).

References

    1. Cummings SR, Nevitt MC, Browner WS, Stone K, Fox KM, Ensrud KE, Cauley J, Black D, Vogt TM. Risk factors for hip fracture in white women. Study of Osteoporotic Fractures Research Group. N Engl J Med. 1995;332:767–773. - PubMed
    1. Hillier TA, Stone KL, Bauer DC, Rizzo JH, Pedula KL, Cauley JA, Ensrud KE, Hochberg MC, Cummings SR. Evaluating the value of repeat bone mineral density measurement and prediction of fractures in older women: The study of osteoporotic fractures. Arch Intern Med. 2007;167:155–160. - PubMed
    1. Siris ES, Chen YT, Abbott TA, Barrett-Connor E, Miller PD, Wehren LE, Berger ML. Bone mineral density thresholds for pharmacological intervention to prevent fractures. Arch Intern Med. 2004;164:1108–1112. - PubMed
    1. Kanis JA, Oden A, Johnell O, Johansson H, De Laet C, Brown J, Burckhardt P, Cooper C, Christiansen C, Cummings S, Eisman JA, Fujiwara S, Gluer C, Goltzman D, Hans D, Krieg MA, La CA, McCloskey E, Mellstrom D, Melton LJ, III, Pols H, Reeve J, Sanders K, Schott AM, Silman A, Torgerson D, van ST, Watts NB, Yoshimura N. The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women. Osteoporos Int. 2007;18:1033–1046. - PubMed
    1. Kanis JA, McCloskey EV, Johansson H, Strom O, Borgstrom F, Oden A. Case finding for the management of osteoporosis with FRAX--assessment and intervention thresholds for the UK. Osteoporos Int. 2008;19:1395–1408. - PubMed

Publication types